Whole-exome sequencing reveals a novel frameshift mutation in a consanguineous family with a hereditary coagulation factor XII deficiency.

[1]  V. Surin,et al.  Factor XII deficiency: a clinical and molecular genetic study , 2023, International Journal of Hematology.

[2]  R. Lockey,et al.  The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update , 2022, The World Allergy Organization journal.

[3]  Dongli Pan,et al.  Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency , 2021, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[4]  A. Akinc,et al.  Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function. , 2020, Thrombosis research.

[5]  C. Maas,et al.  The Fibronectin Type II Domain of Factor XII Ensures Zymogen Quiescence , 2020, Thrombosis and Haemostasis.

[6]  Lihong Yang,et al.  A novel homozygous missense mutation (Met527Ile) in a consanguineous marriage family with inherited factor XII deficiency , 2020, Hematology.

[7]  A. Gruber,et al.  A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain. , 2019, Blood.

[8]  Li-qing Zhu,et al.  Compound heterozygous mutations Glu502Lys and Met527Thr of the FXII gene in a patient with factor XII deficiency , 2019, Hematology.

[9]  C. Maas,et al.  Hereditary angioedema: the plasma contact system out of control , 2018, Journal of thrombosis and haemostasis : JTH.

[10]  F. Lan,et al.  Changes in coagulation factor XII and its function during aortic arch surgery for acute aortic dissection-a prospective observational study. , 2018, Journal of thoracic disease.

[11]  H. Fernandes,et al.  Factor XII Deficiency Mimicking Bleeding Diathesis: A Unique Presentation and Diagnostic Pitfall , 2018, Cureus.

[12]  T. Renné,et al.  Coagulation factor XII in thrombosis and inflammation. , 2018, Blood.

[13]  B. Zuraw.  Hereditary angioedema with normal C1 inhibitor: Four types and counting. , 2018, The Journal of allergy and clinical immunology.

[14]  K. Su,et al.  Genetic analysis of a novel missense mutation (Gly542Ser) with factor XII deficiency in a Chinese patient of consanguineous marriage , 2018, International Journal of Hematology.

[15]  T. Renné,et al.  The plasma contact system, a protease cascade at the nexus of inflammation, coagulation and immunity. , 2017, Biochimica et biophysica acta. Molecular cell research.

[16]  Guo-yong Huang,et al.  Genetic analysis of a hereditary factor XII deficiency pedigree of a consanguineous marriage due to a homozygous F12 gene mutation: Gly341Arg , 2017, Hematology.

[17]  C. Maas,et al.  Factor XII: form determines function , 2016, Journal of thrombosis and haemostasis : JTH.

[18]  B. Wolf,et al.  Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels. , 2016, The Journal of allergy and clinical immunology.

[19]  J. Emsley,et al.  Coagulation factor XII protease domain crystal structure , 2015, Journal of thrombosis and haemostasis : JTH.

[20]  Evi X. Stavrou,et al.  In vivo activation and functions of the protease factor XII , 2014, Thrombosis and Haemostasis.

[21]  H. Saito,et al.  Historical perspective and future direction of coagulation research , 2011, Journal of thrombosis and haemostasis : JTH.

[22]  Y. Miyakawa,et al.  A novel factor XII mutation, FXII R84P, causing factor XII deficiency in a patient with hereditary spastic paraplegia , 2011, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[23]  T. Renné,et al.  In vivo roles of factor XII. , 2010, Blood.

[24]  T. Renné,et al.  A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. , 2010, Blood.

[25]  Evi X. Stavrou,et al.  Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis. , 2010, Thrombosis research.

[26]  A. Schmaier.  The elusive physiologic role of Factor XII. , 2008, The Journal of clinical investigation.

[27]  J. Fontcuberta,et al.  Molecular analysis of multiple genetic variants in Spanish FXII-deficient families , 2007, Haematologica.

[28]  T. Renné,et al.  Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis , 2006, The Journal of experimental medicine.

[29]  G. Emons,et al.  Factor XII deficiency is strongly associated with primary recurrent abortions. , 2003, Fertility and Sterility.

[30]  N. Hamasaki,et al.  A common genetic polymorphism (46 C to T substitution) in the 5'-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. , 1998, Blood.

[31]  T. Renné,et al.  Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[32]  M. Murata,et al.  Factor XII Shizuoka, a novel mutation (Ala392Thr) identified and characterized in a patient with congenital coagulation factor XII deficiency. , 2005, Thrombosis research.